Regulation of V-ATPases by Phosphoinositides
磷酸肌醇对 V-ATP 酶的调节
基本信息
- 批准号:10162616
- 负责人:
- 金额:$ 27.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityBindingBinding SitesBiochemical GeneticsBiological ModelsC-terminalCell CompartmentationCellsCharacteristicsCodeComplexCytosolDefectDiseaseDisseminated Malignant NeoplasmDrug TargetingEndosomesEngineeringEnvironmentEukaryotic CellFunctional disorderFutureGolgi ApparatusHomology ModelingHumanIn VitroIndividualIntracellular MembranesLengthLinkLipid BindingLipidsLysosomesMalignant NeoplasmsMembraneMetastatic toMolecular ConformationMycobacterium InfectionsMycobacterium tuberculosisN-terminalNerve DegenerationNeurodegenerative DisordersOrganellesOsteoporosisPathway interactionsPeripheralPhosphatidylinositolsPhysiologyPlayProcessPropertyProtein IsoformsProteinsProton PumpProtonsRegulationRoleRouteSecretory VesiclesSignal TransductionSignaling MoleculeSodium ChlorideSpecificityStressStructural ModelsStructureSystemTestingToxinTransmembrane DomainVacuoleVirusVirus DiseasesWorkYeastsbasebiological adaptation to stressdevelopmental diseaseexperimental studygenetic approachin vivoinsightloss of function mutationmutantnovelnovel therapeuticspH HomeostasispH gradientpathogenpreferencepublic health relevanceresidenceresponsetherapeutic targetvacuolar H+-ATPase
项目摘要
PROJECT SUMMARY
V-ATPases are highly conserved, multisubunit proton pumps that acidify organelles including
lysosomes, endosomes, Golgi apparatus, and secretory granules in all eukaryotic cells. Each of these
organelles requires tuning of its luminal pH to a narrow range for its function. However, it is not fully
understood how these pH ranges are maintained or how V-ATPases in different organelles respond when
environmental conditions challenge local pH gradients. Our central hypothesis is that PI lipids provide
organelle-specific inputs to locally regulate V-ATPase activity, and thus can impact individual subsets of the
many functions dependent on V-ATPase activity and organelle acidification. In Aim 1, we use the well-
characterized yeast V-ATPase system to characterize binding of the cytosolic domains of the membrane-
bound a-subunit isoforms, Vph1 and Stv1, to phosphoinositide (PI) lipids. We have found that vacuole-resident
Vph1 is able to bind the vacuolar signaling lipid PI(3,5)P2 and Golgi-resident Stv1 prefers the Golgi-enriched
lipid PI(4)P. We will quantify and characterize these binding preferences and probe how binding of specific
lipids activates V-ATPases containing individual a-subunit isoforms. Based on recent structures and homology
modeling, we will then develop lipid-binding mutants for each isoform. Finally, we will evaluate PI binding
specificities of the four human a-subunit isoforms. We have tested three of the four human isoforms and found
evidence of PI-specific interactions in vitro. We will characterize specificity and affinities of PI binding and
identify potential binding sites. In Aim 2, we address the spatial and temporal consequences of PI lipid binding
to intact V-ATPases containing full-length Vph1 and Stv1. We hypothesize that PI lipids exert spatial control by
activating V-ATPases in their organelles of residence. Specifically, we propose that: 1) PI(3,5)P2 binding to
Vph1-containing V-ATPases induces a conformation that stabilizes interactions between the peripheral V1
sector and the integral membrane Vo sector of the V-ATPase, increasing activity, 2) PI(4)P binding to Stv1-
containing V-ATPases promotes retention in the Golgi apparatus, and 3) PI(3)P promotes acidification of the
endocytic pathway by interacting with Vph1-containing V-ATPases. In contrast, hyperosmotic stress promotes
a rapid and transient rise in PI(3,5)P2 that reversibly activates Vph1-containing V-ATPases in the vacuole. We
will analyze the mechanisms of this temporal V-ATPase activation and its role in providing short-term
adaptation to salt stress. These experiments link PI and V-ATPase isoform content, two fundamental features
of organelle identity. They promise to provide novel insights into the many diseases linked to defective
organelle acidification, including neurodegeneration, cancer, and mycobacterial infection, and could suggest
new therapeutic routes.
项目摘要
V-ATP酶是高度保守的多亚基质子泵
所有真核细胞中的溶酶体,内体,高尔基体和分泌颗粒。每个
细胞器需要将其腔内pH调整为狭窄的范围。但是,它不是完全
了解这些pH范围如何保持或不同细胞器中的V-ATP酶的响应
环境条件挑战局部pH梯度。我们的中心假设是Pi脂质提供
细胞器特异性输入以局部调节V-ATPase活性,因此可能影响
许多功能取决于V-ATPase活性和细胞器酸化。在AIM 1中,我们使用了
表征酵母V-ATPase系统以表征膜的胞质结构域的结合
结合a-亚基同工型VPH1和STV1与磷酸肌醇(PI)脂质。我们发现液态居民
VPH1能够结合液泡信号脂质Pi(3,5)P2和Golgi-endent STV1更喜欢Golgi-engeded
脂质pi(4)p。我们将量化和表征这些结合偏好,并探测特定的结合
脂质激活含有单个A-亚基同工型的V-ATP酶。基于最近的结构和同源性
然后,我们将为每种同工型开发脂质结合突变体。最后,我们将评估PI绑定
四个人类A-亚基同工型的特异性。我们已经测试了四种人类同工型中的三个,并发现
体外PI特异性相互作用的证据。我们将表征PI结合的特异性和亲和力,
识别潜在的结合位点。在AIM 2中,我们解决了PI脂质结合的空间和时间后果
到包含全长VPH1和STV1的完整V-ATP酶。我们假设PI脂质通过
在其居住细胞器中激活V-ATP酶。具体而言,我们建议:1)PI(3,5)P2结合到
含VPH1的V-ATP酶诱导构象,使外围V1之间的相互作用稳定
V-ATPase的扇形和整体膜VO部门,活动的增加,2)PI(4)P与STV1-结合
含有V-ATP酶会促进高尔基体的保留率,3)PI(3)P促进了酸化的酸化。
通过与含VPH1的V-ATP酶相互作用的内吞途径。相反,高渗性应力促进
PI(3,5)P2的快速瞬时上升可逆地激活液泡中含有VPH1的V-ATP酶。我们
将分析这种时间V-ATPase激活的机制及其在提供短期的作用
适应盐胁迫。这些实验链接PI和V-ATPase同工型含量,两个基本特征
细胞器的身份。他们承诺将提供与有缺陷有关的许多疾病的新颖见解
细胞器酸化,包括神经变性,癌症和分枝杆菌感染,可以建议
新的治疗路线。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chimeric a-subunit isoforms generate functional yeast V-ATPases with altered regulatory properties in vitro and in vivo.
- DOI:10.1091/mbc.e22-07-0265
- 发表时间:2023-03-01
- 期刊:
- 影响因子:3.3
- 作者:Tuli, Farzana;Kane, Patricia M.
- 通讯作者:Kane, Patricia M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICIA M KANE其他文献
PATRICIA M KANE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICIA M KANE', 18)}}的其他基金
Regulation and Cellular Functions of V-ATPases
V-ATP酶的调节和细胞功能
- 批准号:
10405829 - 财政年份:2022
- 资助金额:
$ 27.54万 - 项目类别:
Regulation and Cellular Functions of V-ATPases
V-ATP酶的调节和细胞功能
- 批准号:
10593953 - 财政年份:2022
- 资助金额:
$ 27.54万 - 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
- 批准号:
6474326 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
- 批准号:
6927940 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
- 批准号:
6608539 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
- 批准号:
6777579 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPase
液泡 H-ATP 酶的亚基结构和功能
- 批准号:
6752136 - 财政年份:1994
- 资助金额:
$ 27.54万 - 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPases
液泡 H-ATP 酶的亚基结构和功能
- 批准号:
8330154 - 财政年份:1994
- 资助金额:
$ 27.54万 - 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPase
液泡 H-ATP 酶的亚基结构和功能
- 批准号:
7068127 - 财政年份:1994
- 资助金额:
$ 27.54万 - 项目类别:
相似国自然基金
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于深度学习预测小分子与人类突变激酶结合亲和力的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
反复非平衡结合联合迭代筛选发掘混合物中痕量高亲和力配体的方法及其应用
- 批准号:82273900
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
全新从头快速设计靶向COVID-19病毒及其突变株S蛋白超高亲和力阻断结合蛋白研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 27.54万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 27.54万 - 项目类别:
Selective targeting of matrix metalloproteinases for developing preterm labor therapeutics
选择性靶向基质金属蛋白酶用于开发早产疗法
- 批准号:
10509786 - 财政年份:2023
- 资助金额:
$ 27.54万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 27.54万 - 项目类别: